Programme

The BSCCP 2019 Programme can be downloaded from the button below.

Click here to download the BSCCP 2019 Trainers Seminar programme

Click here to download the BSCCP 2019 Book of Abstracts

The BSCCP 2019 Programme is displayed below

WEDNESDAY 8TH MAY 2019
10.00 - 13.00Executive Committee Meeting (Invitation Only)
11.00 - 17.30Registration Open
14.30 - 17.30Trainers Seminar (Free to attend but places must be pre-booked)
17.30 - 19.00Welcome Reception
THURSDAY 9TH MAY 2019
08.00 - 17.15Registration Open / Speaker Preview Open and Exhibition Open
09.00 - 09.10Welcome
Jonathan Lippiatt, Chair of the Local Organising Committee
09.10 – 10.20


09.10 – 09.30



09.30 – 10.10

Plenary Session 1
Chairs: Jonathan Lippiatt and Theresa Freeman - Wang

Regulation of Cervical Metaplasia, and the Particular Vulnerability of the Cervical Transformation Zone to HPV-Driven Neoplasia
Professor John Doorbar, University of Cambridge, UK

Biomarker for the Stratification of Cervical Disease
Professor John Doorbar, University of Cambridge, UK
10.10 - 10.20Panel Discussion
10.20 – 10.50


10.20 – 10.35



10.35 – 10.50
Proffered Papers: Session 1
Chairs: Jonathan Lippiatt and Theresa Freeman - Wang

O-1: The use of Human Papillomavirus DNA Methylation in cervical intraepithelial neoplasia: a systematic review and meta-analysis
Dr Sarah Lever, Imperial College London

O-2: Uptake of Cervical Screening In and Around Pregnancy - How Can we Improve It? Qualitative Survey Data From Recently Pregnant Women in Somerset
Dr Sarah Coleridge, Taunton And Somerset Nhs Foundation Trust
10.50 – 11.20Coffee/ Tea/ Exhibition/ Poster Viewing
11.20 – 12.20


11.20 – 12.00



12.00 – 12.30
Plenary Session 2
Chair: Ioannis Biliatis and Jenny Bryrom

Keynote Address: HPV Vaccines – Latest Evidence and Future Developments
Professor Douglas Lowy, National Cancer Institute, USA

An Update on the Outcomes of the HPV Vaccine in Scotland
Professor Maggie Cruickshank, University of Aberdeen, UK
12.30 - 13.10BSCCP AGM
13.10 - 14.10Lunch Exhibition / Poster Viewing
14.10 – 14.30


14.00 – 14.10


14.10 – 14.30
Plenary Session 3
Chairs: Rachana Dwivedi and Maggie Cruickshank

Presentation of Founders Medal: Maggie Cruickshank, UK
Presented to: Dr Björn Strander, Regional Cancer Centre West Sweden, Sweden

Screening participation and colposcopy - pillars of cervical cancer prevention
Dr Björn Strander, Regional Cancer Centre West Sweden, Sweden

14.30 – 15.15


14.30 – 14.45



14.45 – 15.00

15.00 – 15.15
Proffered Papers: Session 2
Chairs: Padma Eederapalli and Maggie Cruickshank

O-3: Good performance of p16/Ki-67 dual-stained cytology for detection and post-treat surveillance of high-grade CIN/VAIN in a retrospective study
Mrs Qin Yao, Department Of Obstetrics And Gynaecology, Affiliated Hospital Of Qingdao University, Qingdao, China

O-4: Risk of developing vaginal cancer among hysterectomised women with cervical intraepithelial neoplasia or cervical cancer- a population based national cohort study
Dr Emilia Alfonzo, Sahlgrenska University Hospital, Gothenburg, Sweden

O-5: Cervical Intraepithelial Neoplasia and Cervical Cancer: A Genome-wide Association Study (GWAS) of the UK Biobank
Dr Sarah Lever, Imperial College London
15.15 - 15.45Coffee/ Tea/ Exhibition/ Poster Viewing
15.45 – 17.15


15.45 – 16.15


16.15– 17.15

Plenary Session 4
Chairs: Anni Innamaa and Deirdre Lyons

Cervical Cell Changes: The Patient Experience
Rebecca Shoosmith, Head of Support Services, Deputy Chief Executive, Jo’s Cervical Cancer Trust

MDT
19.30 - MidnightReception and BSCCP Conference Dinner (numbers limited)
FRIDAY 10TH MAY 2019
08.00 - 17.10Registration Open / Speaker Preview Open
09.00 - 13.30BSCCP 2019 Sessions / Exhibition / Posters
09.00 – 10.10


09.00 – 09.25


09.25 – 09.55
Plenary Session 5
Chairs: Louise Melson and Nicholas Myerson

Global Neglect of Gynaecological Disease
Professor Alison Fiander, RCOG, UK

Worldwide Initiatives for Prevention of Cervical Cancers
Dr Parthu Basu, International Agency for Research on Cancer, France
09.55 – 10.05Panel Discussion
10.05 – 10.35


10.05 – 10.20



10.20 – 10.35
Proffered Papers: Session 3
Chairs: Louise Melson and Nicholas Myerson

O-6: Primary cervical screening with high-risk human papillomavirus testing: Evaluation of the English screening pilot
Professor John Tidy, Sheffield Teaching Hospital Nhs Foundation Trust

O-7: Screening Performance of the HPV Primary Early Adopters Phase in Wales
Dr Louise Pickford, Cervical Screening Wales
10.35 – 11.05Coffee/ Tea/ Exhibition/ Poster Viewing
11.05 – 12.25


11.05 – 11.35


11.35 – 12.05



12.05 – 12.25
Plenary Session 6
Chairs: John Tidy and Jacob Bornstein

Primary HPV Screening
Professor Peter Sasieni, Kings College London, UK

A Laboratory Perspective on HPV Primary Screening: Lessons from the Pilot and Practical Aspects of Implementation
Dr Karin Denton, NHS North Bristol Trust, UK

Hot Topics in QA
Ms Philippa Pearmain, Public Health England, UK
12.25 – 13.30Lunch/ Exhibition/ Poster Viewing
13.30 – 14.40


13.30 – 13.50


13.50 – 14.10


14.10 – 14.30
Plenary Session 7
Chairs: Abi Kingston and Theresa Freeman - Wang

HPV Related Disease – Head and Neck
Dr Emma King, Poole Hospital, UK

HPV Related Disease – Anal
Ms Tamzin Cuming, Homerton University Hospital, UK

HPV Related Disease – Vulva
Dr Sadie Jones, University Hospital of Wales, UK
14.30 – 14.40Colposcopic Terminology of the Cervix and the Lower Genital Tract - An International Perspective.
Professor Jacob Bornstein, Galilee Medical Center, Israel
14.40 – 15.25


14.40 – 14.55


14.55 – 15.10




15.10 – 15.25
Proffered Papers: Session 4
Chairs: Abi Kingston and Theresa Freeman – Wang

O-8: Prospective Audit of Conservative Management of CIN2
Miss Anni Innamaa, Poole Hospital NHS Foundation Trust

O-9: Conservative Management of Stage IA Cervical Cancer: Outcomes Following Loop Excision as a Fertility Sparing Policy with Critical Emphasis on Margin Status
Mr Porfyrios Korompelis, NGOC

O-10: Comparison of 3 colposcopy training simulator for effective training in cervical cancer prevention
Dr Ida Ismail-pratt, National University Hosiptal, Singapore
15.25 – 16.25


15.25 – 15.45


15.45 – 16.05


16.05 – 16.25
Plenary Session 8
Chairs: Anni Innamaa and Pierre Martin - Hirsch

Prophylactic Vaccine Trial
Dr Maria Kyrgiou, Imperial College London, UK

HPV Therapeutic Vaccines
Dr Karin Hellner, University of Oxford, UK

Response to LACC Trial
Professor Pierre Martin - Hirsch, Lancashire Teaching Hospitals, UK
16.25 – 16.35Presentation of Prizes and Closing Remarks
Coffee will be available on departure